Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://ncbi.nlm.nih.gov/pubmed/25985893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1404-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi